Ron E. Swensen

745 total citations
30 papers, 549 citations indexed

About

Ron E. Swensen is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Ron E. Swensen has authored 30 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Reproductive Medicine, 8 papers in Surgery and 8 papers in Obstetrics and Gynecology. Recurrent topics in Ron E. Swensen's work include Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). Ron E. Swensen is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). Ron E. Swensen collaborates with scholars based in United States, Canada and Ireland. Ron E. Swensen's co-authors include Heidi J. Gray, Barbara A. Goff, Adnan Munkarah, Haider Mahdi, Sanjeev Kumar, Mary L. Disis, Lupe G. Salazar, Chirag Shah, Vivian Goodell and Hisham K. Tamimi and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Gynecologic Oncology.

In The Last Decade

Ron E. Swensen

28 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ron E. Swensen United States 15 218 187 183 148 114 30 549
Mehmet Ali Vardar Türkiye 14 220 1.0× 161 0.9× 111 0.6× 235 1.6× 78 0.7× 72 636
Andrea Miranda Italy 16 373 1.7× 106 0.6× 226 1.2× 275 1.9× 43 0.4× 39 703
Tine Henrichsen Schnack Denmark 17 324 1.5× 111 0.6× 264 1.4× 188 1.3× 36 0.3× 46 729
Jitti Hanprasertpong Thailand 17 210 1.0× 217 1.2× 102 0.6× 288 1.9× 27 0.2× 52 672
Eduard Malik Germany 19 454 2.1× 72 0.4× 206 1.1× 371 2.5× 129 1.1× 62 763
Beryl Manning‐Geist United States 13 178 0.8× 112 0.6× 139 0.8× 122 0.8× 29 0.3× 49 458
Douglas V. Horbelt United States 12 117 0.5× 97 0.5× 56 0.3× 86 0.6× 64 0.6× 26 384
Anette Kjærbye‐Thygesen Denmark 11 242 1.1× 94 0.5× 69 0.4× 131 0.9× 45 0.4× 22 431
Katharine M. Esselen United States 15 202 0.9× 134 0.7× 92 0.5× 174 1.2× 20 0.2× 39 621
M. E. Crowther United Kingdom 13 100 0.5× 250 1.3× 85 0.5× 122 0.8× 68 0.6× 25 603

Countries citing papers authored by Ron E. Swensen

Since Specialization
Citations

This map shows the geographic impact of Ron E. Swensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron E. Swensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron E. Swensen more than expected).

Fields of papers citing papers by Ron E. Swensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron E. Swensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron E. Swensen. The network helps show where Ron E. Swensen may publish in the future.

Co-authorship network of co-authors of Ron E. Swensen

This figure shows the co-authorship network connecting the top 25 collaborators of Ron E. Swensen. A scholar is included among the top collaborators of Ron E. Swensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron E. Swensen. Ron E. Swensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, John B., William R. Gwin, Yushe Dang, et al.. (2024). Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer. Gynecologic Oncology. 191. 74–79. 1 indexed citations
2.
Liao, John B., William R. Gwin, Renata R. Urban, et al.. (2021). Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates. Journal for ImmunoTherapy of Cancer. 9(9). e003122–e003122. 17 indexed citations
3.
Liao, John B., Ron E. Swensen, Leonard D’Amico, et al.. (2017). Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer. Gynecologic Oncology. 144(3). 480–485. 13 indexed citations
4.
Urban, Renata R., Ron E. Swensen, Jay Schulkin, & Melissa A. Schiff. (2016). Implementing the "Flipped Classroom" on a Gynecologic Oncology Service.. PubMed. 61(9-10). 405–410. 6 indexed citations
5.
Liao, John B., Ron E. Swensen, Jennifer S. Childs, et al.. (2015). Phase II trial of weekly nab-paclitaxel with GM-CSF as an immune modulator in recurrent platinum resistant ovarian, fallopian tube, and primary peritoneal cancer: Clinical and immune responses.. Journal of Clinical Oncology. 33(15_suppl). 5580–5580. 3 indexed citations
6.
Mahdi, Haider, Sanjeev Kumar, Rabbie K. Hanna, et al.. (2011). Disparities in treatment and survival between African American and White women with vaginal cancer. Gynecologic Oncology. 122(1). 38–41. 7 indexed citations
7.
Mahdi, Haider, Ron E. Swensen, Rabbie K. Hanna, et al.. (2011). Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary. British Journal of Cancer. 105(4). 493–497. 59 indexed citations
8.
Mahdi, Haider, et al.. (2011). Suicide in women with gynecologic cancer. Gynecologic Oncology. 122(2). 344–349. 21 indexed citations
9.
Dunsmoor-Su, Rebecca, et al.. (2011). Pelvic exenteration in the age of modern chemoradiation. Gynecologic Oncology. 121(1). 131–134. 39 indexed citations
11.
Press, Joshua Z., Kimberly H. Allison, Rochelle L. Garcia, et al.. (2010). FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence. Gynecologic Oncology. 120(2). 296–299. 16 indexed citations
12.
Salazar, Lupe G., Ron E. Swensen, Andrew L. Coveler, et al.. (2008). Phase I study of intraperitoneal (IP) denileukin diftitox in patients with advanced ovarian cancer (OC). Journal of Clinical Oncology. 26(15_suppl). 3036–3036. 2 indexed citations
13.
Shah, Chirag, Elizabeth M. Swisher, Rochelle L. Garcia, et al.. (2008). An evaluation of cervical cancer in women age sixty and over. Gynecologic Oncology. 109(1). 53–58. 13 indexed citations
14.
Salazar, Lupe G., Andrew L. Coveler, Ron E. Swensen, et al.. (2007). Kinetics of tumor-specific T-cell response development after active immunization in patients with HER-2/neu overexpressing cancers. Clinical Immunology. 125(3). 275–280. 15 indexed citations
15.
Goodell, Vivian, Lupe G. Salazar, Nicole Urban, et al.. (2006). Antibody Immunity to the p53 Oncogenic Protein Is a Prognostic Indicator in Ovarian Cancer. Journal of Clinical Oncology. 24(5). 762–768. 113 indexed citations
16.
Swisher, Elizabeth M., Ron E. Swensen, Benjamin E. Greer, et al.. (2005). Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: A phase I trial of the Puget Sound Oncology Consortium. Gynecologic Oncology. 101(3). 429–435. 23 indexed citations
17.
Swensen, Ron E., et al.. (2004). Radiofrequency ablation of liver metastasis from ovarian adenocarcinoma: case report and literature review. Gynecologic Oncology. 93(2). 557–560. 21 indexed citations
18.
Swensen, Ron E. & Wolff M. Kirsch. (2002). Brain Neoplasms in Women: A Review. Clinical Obstetrics & Gynecology. 45(3). 904–927. 16 indexed citations
19.
Lemelin, Jacques, Stephen B. Hotz, Ron E. Swensen, & Tom Elmslie. (1994). Depression in primary care. Why do we miss the diagnosis?. PubMed. 40. 104–8. 25 indexed citations
20.
Swensen, Ron E., et al.. (1990). An Ovarian Cancer Tumor Marker, CA 125, Comes of Age.. PubMed. 152(4). 406–406. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026